Benzylideneacetone Derivatives Inhibit Osteoclastogenesis and Activate Osteoblastogenesis Independently Based on Specific Structure–Activity Relationship-Reference-Cited by-同舟云学术

Benzylideneacetone Derivatives Inhibit Osteoclastogenesis and Activate Osteoblastogenesis Independently Based on Specific Structure–Activity Relationship

Published:2019-06-19 Issue:13 Volume:62 Page:6063-6082
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Pativada Triveni¹,Kim Myung Hwan¹,Lee Jung-Hun²,Hong Seong Su²,Choi Chun Whan²,Choi Yun-Hyeok²,Kim Woo Jung²,Song Da-Woon²,Park Serk In¹,Lee Eun Jung¹,Seo Bo-Yeon¹,Kim Hankyeom³,Kim Hong Kyu⁴,Lee Kee Ho⁵,Ahn Sung K.⁶,Ku Jin-Mo²^ORCID,Park Gil Hong¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, College of Medicine, Korea Molecular Medicine and Nutrition Research Institute, Korea University, Seoul 02841, Korea

2. Bio-Center, Gyeonggido Business & Science Accelerator, Suwon 16229, Korea

3. Department of Pathology, Korea University Guro Hospital, Seoul 08308, Korea

4. Department of Surgery, Seoul National University Hospital, Seoul 03080, Korea

5. Division of Radiation Cancer Research, Korea Institute of Radiological and Biomedical Sciences, Seoul 01812, Korea

6. Statistics, Department of Finance and Management Science, College of Business, Washington State University, Pullman, Washington 99164-4746, United States

Funder

National Research Foundation of Korea

Korea University

Korea University Medical Center Research and Business Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00270

Reference65 articles.

1. Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis